Size of the sample for clinical trials. how many patients are required?
Schødt, T.
Ugeskrift for Laeger 148(37): 2333-2335
1986
ISSN/ISBN: 0041-5782 PMID: 3775918 Document Number: 275753
Document emailed within 1 workday
Related Documents
Bellamy, N.; Anastassiades, T.P.; Buchanan, W.W.; Davis, P.; Lee, P.; McCain, G.A.; Wells, G.A.; Campbell, J. 1991: Rheumatoid arthritis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials of antirheumatic drugs Journal of Rheumatology 18(12): 1901-1907Neuhäuser, M.; Jöckel, K.H. 2006: Methacholine challenge tests: sample sizes required in crossover trials International Journal of Clinical Pharmacology and Therapeutics 44(1): 27-30
Parker, M. 2001: Sample size and statistical power of randomised, controlled trials in orthopaedics Journal of Bone and Joint Surgery. British Volume 83(8): 1210
Wang, R.; Goyal, R.; Lei, Q.; Essex, M.; De Gruttola, V. 2014: Sample size considerations in the design of cluster randomized trials of combination HIV prevention Clinical Trials 11(3): 309-318
Luna del Castillo, J.; Martín Andrés, A. 1990: "and now, how many subjects do i take?" Some basic ideas on sample size (II): sample size in a problem of contrasting hypotheses with 2 samples Atencion Primaria 7(2): 152-155
Sabharwal, S.; Patel, N.K.; Holloway, I.; Athanasiou, T. 2015: Sample size calculations in orthopaedics randomised controlled trials: revisiting research practices Acta Orthopaedica Belgica 81(1): 115-122
Ang, R.P. 2003: Randomised controlled trials (RCTs)--sample size: the magic number (SMJ Vol 44 Issue 4 April 2003) Singapore Medical Journal 44(8): 432
Pope, J.E.; Bellamy, N. 1995: Sample size calculations in scleroderma: a rational approach to choosing outcome measurements in scleroderma trials Clinical and Investigative Medicine 18(1): 1-10
Vega Ramos, B.; Peraza Yanes, O.; Herrera Correa, G.; Saldívar Toraya, S. 1996: Practical aspects regarding sample size in clinical research Revista de Gastroenterologia de Mexico 61(3): 246-251
Lund, L.H. 2008: Ethics committees in USA--background and development. Responsible conductors of clinical trials required for risk minimization Lakartidningen 105(1-2): 42-44
Rabin, R.L.; Slater, J.E.; Lachenbruch, P.; Pastor, R.W. 2003: Sample size considerations for establishing clinical bioequivalence of allergen formulations Arbeiten aus dem Paul-Ehrlich-Institut Zu Frankfurt A.M 94: 24-33
William, T.B.; Robert, S. Justin, S.B. 2012: The effects of small sample size and sample bias on threshold selection and accuracy assessment of species distribution models Ecography 35(3): 250-258
Baldini, C.; Delle Sedie, A.; Bombardieri, S. 2005: From clinical trials to the bedside: how can we treat patients with rheumatoid arthritis and concurrent morbidities who are generally excluded from randomised controlled clinical trials? Clinical and Experimental Rheumatology 23(6): 893-904
Ivers, N.M.; Taljaard, M.; Dixon, S.; Bennett, C.; McRae, A.; Taleban, J.; Skea, Z.; Brehaut, J.C.; Boruch, R.F.; Eccles, M.P.; Grimshaw, J.M.; Weijer, C.; Zwarenstein, M.; Donner, A. 2011: Impact of CONSORT extension for cluster randomised trials on quality of reporting and study methodology: review of random sample of 300 trials, 2000-8 Bmj 343: D5886
Richman, D.; Itri, L.; Johnson, M.F.; Eigo, J. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--active control (equivalence) trials Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S88
Counsell, C. 1998: Effect of adding selegiline to levodopa in early, mild Parkinson's disease. Formal systematic review of data on patients in all relevant trials is required Bmj 317(7172): 1586
Mandal, A.K. 2012: A more representative sample is required National Medical Journal of India 25(5): 312
Lietman, P.; Temple, R.; Harrington, M.; Peck, C. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--approaches to clinical trials design Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S27
Colditz, G.A. 1996: Selenium and cancer prevention. Promising results indicate further trials required JAMA 276(24): 1984-1985
Curtis, C.R.; Salman, M.D.; Shott, S. 1990: Power and sample size Journal of the American Veterinary Medical Association 197(7): 838-840